The global joint pain injections market, valued at USD 5.75 billion in 2024, is projected to reach USD 6.23 billion in 2025 and USD 12.09 billion by 2035, representing a CAGR of 6.9% during the forecast period. As per the report of the World Health Organization, osteoarthritis is getting more prevalent among aged people (nearly 70% of people, about 55 years of age). Among these, nearly 60% of the population with osteoarthritis are women. Moreover, people specifically athletes and individual with...

The global sports medicine market is currently valued at USD 6.30 billion in 2024 and is expected to reach USD 6.78 billion in 2025 and USD 12.33 billion by 2035, representing a compounded annual growth rate (CAGR) of 6.2% during the forecast period. A recent report published by National Institute of Health stated that in 2024, athletic trainers reported around 15,631 injuries during 6,778,209 athletic exposures. Notably, the most common injured areas of the body due to sports activities include...

The global cosmetic surgery market, valued at USD 59.71 billion in 2024, is expected to grow to 62.98 USD billion in 2025 and USD 96.76 billion by 2035, representing a higher CAGR of 4.4% during the forecast period. In January 2025, Galderma announced positive first results of Restylane

The global pulse oximeter market size is worth around USD 2.8 billion currently and is estimated to reach USD 6.6 billion by 2035, representing a CAGR of 8.1% during the forecast period. It is worth noting here that nearly 43 states of the United States have mandated the use of pulse oximeters for newborn baby screenings to identify respiratory diseases, and congenital heart diseases. Driven by the growing usage, several players engaged in this market have shown keen interest for the development...

The global human factors and usability engineering services market, valued at USD 1.01 billion in 2025, is projected to reach USD 1.09 billion in 2026 and USD 1.97 billion by 2035, representing a CAGR of 6.7% during the forecast period. Market growth over the next decade is expected to be driven by increased technological innovations leading to the development of complex medical devices that require stringent regulatory review. Further, the heightened focus on user’s safety along with the need...

The global life science analytics market is valued at USD 10.79 billion in 2024, is projected to reach USD 11.74 billion in 2025 and USD 23.73 billion by 2035, representing a higher CAGR of 7.3% during the forecast period. Based on our life science analytics market forecast, presently, North America holds the dominant position, accounting for ~52% share of the market. North America has advanced healthcare infrastructure and life science industrial players in this region are increasingly adopting...

The global non-muscle invasive bladder cancer market, valued at USD 2.92 billion in 2024, is projected to reach USD 3.47 billion in 2025 and USD 14.01 billion by 2035, representing a CAGR of 15.0% during the forecast period. Non-muscle invasive bladder cancer (NMIBC) is a form of early-stage cancer that remains confined to the inner linings of the bladder. Recently, there has been a surge in the cases of non-muscle invasive bladder cancer among the population worldwide. A recent report by ACS es...

Computer vision in healthcare market, valued at USD 2.54 billion in 2024, is estimated to reach USD 3.77 billion in 2025 and USD 59.44 billion by 2035, representing a CAGR of 31.8% during the forecast period. In October 2024, Ataraxis AI raised funding of USD 4 million in seed funding round co-led by Giant Ventures and Obvious Ventures. The funding is utilized by Ataraxis for the development of AI-powered diagnostic tests. Notably, the company offers Ataraxis Breast, first AI-native prognostic...

The global nutraceuticals market, valued at USD 483.49 billion in 2024, is projected to reach USD 521.04 billion in 2025 and USD 969.11 billion by 2035, representing a CAGR of 6.4% during the forecast period. According to the recent report published by World Health Organization, nearly 830 million people globally have diabetes and approximately half of the people with diabetes are not receiving any treatment. In addition to diabetes, obesity is one of the most prevailing condition across the glo...

The global natural language processing (NLP) in healthcare and life sciences market, valued at USD 3.26 billion in 2024, is projected to reach USD 3.99 billion in 2025 and USD 20.04 billion by 2035, representing a CAGR of 17.5% during the forecast period. Examples of key players engaged in this domain (which have also been captured in this report) include 10x Genomics, Amazon, Caresyntax, Cerner, Mayo Clinic, Epic Systems, Google, Health Catalyst, IBM, Invitae, Microsoft, Nuance Communications,...

The global single-cell omics market is estimated to grow from USD 3.89 billion in 2025 to USD 17.01 billion by 2035, representing a CAGR of 15.90% during the forecast period. Based on the type of product, the global market is segmented into instruments and consumables. According to our analysis, presently instruments hold the highest share (nearly 60%) of the market and this segment is likely to remain dominant over the forecast period. Instruments, such as flow cytometers, single-cell RNA seque...

The antimicrobial resistance surveillance market is valued at USD 6.64 billion in 2025 and is estimated to reach USD 11.32 billion by 2035, representing a higher CAGR of 5.47% during the forecast period. Antimicrobial resistance has become a major concern for healthcare experts as it creates challenges in the treatment of patients. As per the report of Centers for Disease Control and Prevention, over 2.8 million antimicrobial-resistance infections occur annually in the US. Moreover, the World H...

The global cannabis market, valued at USD 39.21 billion in 2024, is expected to reach USD 47.76 billion in 2025 and USD 231.81 billion by 2035, representing a healthy CAGR of 17.1% during the forecast period. It is important to highlight here that cannabis industrial players and several government organizations are making considerable investments in this field to promote the legal adoption of cannabis for medicinal and recreational purposes. For instance, in June 2024, New York City Economic Dev...

The global companion animal health market size, valued at USD 24.50 billion in 2024, is projected to reach USD 26.53 billion in 2025 and USD 51.45 billion by 2035, representing a CAGR of 6.8% during the forecast period. In April 2024, European Commission announced the European Partnership for Animal Health and Welfare. Under this partnership 56 European research institutes and 30 funding organizations along with Austrian Science Fund teamed up to combat the risk of infectious diseases in animals...

The global cannabidiol oil market, valued at USD 7.22 billion in 2024, is estimated to grow to USD 8.89 billion in 2025 and USD 50.05 billion by 2035, representing a higher CAGR of 18.86% during the forecast period. On the basis of the type of product, the global cannabidiol oil market is segmented into original oil and blended oil. Among these, currently original oil accounts for the highest share (nearly 65%) of the market. This dominance is due to the fact that original oil has high concentra...

The global sterile injectable contract manufacturing market is expected to grow from USD 14.4 billion in 2024 to USD 33.7 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 8% during the forecast period. Examples of the leading companies engaged in this industry (the complete list of key players has also been listed in the detailed report) include Aenova Group, Baxter, Boehringer Ingelheim, Catalent, Cipla, Fresenius Kabi, Famar, Grifols, NextPharma Technologies...

The global artificial intelligence (AI) in healthcare market size, valued at USD 22.61 billion in 2024, is expected to reach USD 35.71 billion in 2025 and USD 765.12 billion by 2035, representing a higher CAGR of 35.9% during the forecast period. Earlier in February 2024, All India Institute of Medical Sciences (AIIMS) Delhi, India has launched an AI system that was trained by utilizing a data set of 500,000 radiological and histopathological images taken from 1,500 patients of breast and ovaria...

The global gene therapy market, valued at USD 4.20 billion in 2025, is projected to reach USD 6.07 billion in 2026 and USD 20.47 billion by 2035, with a 14.5% CAGR during the forecast period 2026 to 2035. According to the World Health Organization (WHO), 10 out of every 1,000 individuals are affected by genetic disorders, with over 70 million people worldwide living with such conditions. In fact, more than 40% of infant mortality globally is associated with various genetic disorders. Therefore...

North America women's digital health market is estimated to be worth USD 1,404 million in 2024 and is expected to reach USD 10,477 million by 2035; it is estimated to grow at a compounded annual growth rate (CAGR) of 19.2% during the forecast period. It is worth noting here that women comprise 49.6% of the global population, and as per the US Department of Labor report, females use digital healthcare solutions more than men. According to a research report, women in the United States have the hig...

The patient centric healthcare app market, valued at USD 15.07 billion in 2024, is projected to grow to USD 24.83 billion in 2025 and USD 646.52 billion by 2035, representing a CAGR of 38.5% during the forecast period. According to our market data analysis, android operating systems holds the majority of the share (50%), driven by widespread adoption. It is important to highlight here that android has open-source nature that supports wide range of applications on smartphones and tablets. Owing t...